Table 1. Demographic, clinical, and laboratory participant characteristics in SMC and non-SMC population.
SMC population 2012 (N = 662) | SMC population 2014 (N = 670) | NON-SMC population 2014 (N = 502) | ||||
---|---|---|---|---|---|---|
n | %/median | n | %/median | n | %/median | |
Sex ratio (female) | 361 | 54.5% | 333 | 49.7% | 304 | 60.6% |
Age | 661 | 2 years | 670 | 3 years | 502 | 20 years |
Urban | 192 | 28.7% | 190 | 28.4% | 150 | 29.9% |
History of fever | 213 | 32.2% | 104 | 15.5% | 401 | 79.9% |
Fever | 43 | 6.5% | 16 | 2.4% | 251 | 50% |
P. falciparum | 190 | 28.8% | 83 | 12.4% | - | - |
P. malariae | 2 | 0.3% | 3 | 0.5% | - | - |
P. ovale | 3 | 0.5% | 0 | 0% | - | - |
Gametocyte | 60 | 9.1% | 15 | 2.2% | - | |
TDR (+) | 43 | 6.5% | 16 | 2.4% | 359 | 71.5% |
Haemoglobin <11g/dl | 446 | 67.5% | 336 | 50.2% | - |
RTD, Rapid diagnostic test; n, number with positive; N, number of participants.